Four years ago, a pharmaceutical company was considering the…
Four years ago, a pharmaceutical company was considering the development of a new drug called Zeno for treating Type-2 Diabetes. The company spent $2 million on a feasibility study. Based on the feasibility study, the company decided to spend (and did spend) $14 million on research and development. The company decided not to undertake the development of Zeno. However, as of today, management believes that developing Zeno might be worthwhile to undertake and wants to calculate the NPV associated with developing Zeno. In the calculation of NPV for deciding whether to develop Zeno, how much should be included for the cost of the project?
Read Details